Finally, we assessed hepatic gene expression levels of GNA12 and GNA13 using liver biopsy samples obtained from human subjects with metabolic dysfunction-associated steatotic liver disease (MASLD; n = 24). This evidence concerns the gene GNA13 and metabolic dysfunction-associated steatotic liver disease.